Federal
Register Notices > Notice of
Application 2006 >
Lilly Del Caribe, Inc.
FR Doc E6-7977 [Federal Register: May 25, 2006 (Volume 71, Number 101)]
[Notices] [Page 30166] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr25my06-86]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec.
1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is
notice that on February 22, 2006, Lilly Del Caribe, Inc., Chemical Plant,
Kilometer 146.7, State Road 2, Mayaguez, Puerto Rico 00680, made application by
renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk
manufacturer of Dextropropoxyphen (9273), a basic class of controlled substance
listed in Schedule II.
The company plans to manufacture the listed controlled substances in bulk for
distribution to its customers. Any other such applicant and any person who is
presently registered with DEA to manufacture such a substance may file comments
or objections to the issuance of the proposed registration pursuant to 21 CFR
1301.33(a).
Any such written comments or objections being sent via regular mail may be
addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement Administration, Washington, DC 20537,
Attention: DEA Federal Register Representative, Liaison and Policy Section (ODL);
or any being sent via express mail should be sent to DEA Headquarters,
Attention: DEA Federal RegisterRepresentative/ODL, 2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be filed no later than July 24, 2006.
Dated: May 17, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E6-7977 Filed 5-24-06; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|